Next Article in Journal
Structural Insights into the Molecular Evolution of the Archaeal Exo-β-d-Glucosaminidase
Next Article in Special Issue
Chemokine CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute T Cell-Mediated Kidney Allograft Rejection
Previous Article in Journal
Short-Term Protocols to Obtain Insulin-Producing Cells from Rat Adipose Tissue: Signaling Pathways and In Vivo Effect
Previous Article in Special Issue
Renal Regenerative Potential of Extracellular Vesicles Derived from miRNA-Engineered Mesenchymal Stromal Cells
Article Menu
Issue 10 (May-2) cover image

Export Article

Open AccessReview

Mesenchymal Stem Cells—Potential Applications in Kidney Diseases

Psychiatric Services of Thurgovia, Academic Teaching Hospital of the Medical University of Salzburg, 8596 Münsterlingen, Switzerland
General Practice, 43-426 Dębowiec, Poland
Regional Blood Donation and Blood Treatment Centre, 40-074 Katowice, Poland
DaVita Dialysis, 42-700 Lubliniec, Poland
Department of Internal Medicine, Diabetology and Nephrology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, 41-800 Zabrze, Poland
Author to whom correspondence should be addressed.
These authors contributed equally to this paper.
Int. J. Mol. Sci. 2019, 20(10), 2462;
Received: 29 March 2019 / Revised: 16 May 2019 / Accepted: 16 May 2019 / Published: 18 May 2019
(This article belongs to the Special Issue Kidney Inflammation, Injury and Regeneration)
PDF [620 KB, uploaded 18 May 2019]


Mesenchymal stem cells constitute a pool of cells present throughout the lifetime in numerous niches, characteristic of unlimited replication potential and the ability to differentiate into mature cells of mesodermal tissues in vitro. The therapeutic potential of these cells is, however, primarily associated with their capabilities of inhibiting inflammation and initiating tissue regeneration. Owing to these properties, mesenchymal stem cells (derived from the bone marrow, subcutaneous adipose tissue, and increasingly urine) are the subject of research in the settings of kidney diseases in which inflammation plays the key role. The most advanced studies, with the first clinical trials, apply to ischemic acute kidney injury, renal transplantation, lupus and diabetic nephropathies, in which beneficial clinical effects of cells themselves, as well as their culture medium, were observed. The study findings imply that mesenchymal stem cells act predominantly through secreted factors, including, above all, microRNAs contained within extracellular vesicles. Research over the coming years will focus on this secretome as a possible therapeutic agent void of the potential carcinogenicity of the cells. View Full-Text
Keywords: mesenchymal stem cell; mesodermal stem cell; renal ischemia-reperfusion; inflammation; kidney transplantation; microRNA; extracellular vesicles; exosomes mesenchymal stem cell; mesodermal stem cell; renal ischemia-reperfusion; inflammation; kidney transplantation; microRNA; extracellular vesicles; exosomes

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Bochon, B.; Kozubska, M.; Surygała, G.; Witkowska, A.; Kuźniewicz, R.; Grzeszczak, W.; Wystrychowski, G. Mesenchymal Stem Cells—Potential Applications in Kidney Diseases. Int. J. Mol. Sci. 2019, 20, 2462.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top